• Publications
  • Influence
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
The field of spondyloarthritis (SpA) has experienced major progress in the last decade, especially with regard to new treatments, earlier diagnosis, imaging technology and a better definition ofExpand
  • 943
  • 99
  • PDF
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group
Background: Magnetic resonance imaging (MRI) of sacroiliac joints has evolved as the most relevant imaging modality for diagnosis and classification of early axial spondyloarthritis (SpA) includingExpand
  • 641
  • 33
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literatureExpand
  • 856
  • 27
  • PDF
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one setExpand
  • 625
  • 27
  • PDF
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
BACKGROUND Secukinumab is an anti-interleukin-17A monoclonal antibody that has been shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted two phase 3 trials ofExpand
  • 512
  • 23
  • PDF
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group
Objectives To review and update the existing definition of a positive MRI for classification of axial spondyloarthritis (SpA). Methods The Assessment in SpondyloArthritis International Society (ASAS)Expand
  • 221
  • 17
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
OBJECTIVE Ankylosing spondylitis (AS) is diagnosed late, because radiographs of the sacroiliac joints often do not show definite sacroiliitis at the time of disease onset. The aim of this study wasExpand
  • 534
  • 15
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
OBJECTIVE To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis (AS) who underwent anti-tumor necrosis factor (anti-TNF) therapy, using data from recently performedExpand
  • 365
  • 13
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice
A taskforce comprised of an expert group of 21 rheumatologists, radiologists and methodologists from 11 countries developed evidence-based recommendations on the use of imaging in the clinicalExpand
  • 254
  • 13
  • PDF
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
BACKGROUND Ankylosing spondylitis is a chronic immune-mediated inflammatory disease characterised by spinal inflammation, progressive spinal rigidity, and peripheral arthritis. Interleukin 17 (IL-17)Expand
  • 446
  • 12
  • PDF
...
1
2
3
4
5
...